肝脏 ›› 2025, Vol. 30 ›› Issue (8): 1084-1088.

• 肝纤维化及肝硬化 • 上一篇    下一篇

瞬时弹性成像检测肝、脾脏硬度联合超声检测门静脉内径评估慢性丙型肝炎肝纤维化的价值

杨月华, 符进   

  1. 226600 江苏 海安市人民医院超声科
  • 收稿日期:2024-03-05 发布日期:2025-09-19
  • 通讯作者: 杨月华,Email:cainantong189@163.com

The value of instantaneous elastic imaging to detect the hardness of liver and spleen combined with doppler ultrasound to detect the inner diameter of portal vein in assessing chronic hepatitis C liver fibrosis

YANG Yue-hua, FU Jin   

  1. Department of Ultrasound, People′s Hospital of Hai′an City, Hai′an 226600,China
  • Received:2024-03-05 Published:2025-09-19
  • Contact: YANG Yue-hua, Email: cainantong189@163.com

摘要: 目的 探讨瞬时弹性成像(TE)检测肝脏硬度(LSM)、脾脏硬度(SSM)联合彩色多普勒超声(CDUS)检测门静脉内径(PVD)对慢性丙型肝炎(CHC)肝纤维化的临床价值。 方法 选择海安市人民医院超声科2021年6月至2023年10月收治的94例CHC患者列入观察组,以及同期70例健康体检人员列入对照组。两组均行TE检测LSM和SSM、CDUS检测PVD;采集空腹血样检测并计算红细胞分布宽度与血小板计数比值(RPR)、肝纤维化-4因子指数(FIB-4)和血清白蛋白-胆红素(ALBI)水平。观察组患者在CDUS引导下行肝穿刺活检,根据Scheuer法进行肝纤维化分期。比较观察组和对照组,以及观察组不同肝纤维化分期的LSM、SSM和PVD水平,应用Pearson相关性分析评估CHC患者LSM、SSM、PVD与RPR、FIB-4和ALBI水平的相关性,绘制受试者工作特征(ROC)曲线分析单独和联合检测LSM、SSM和PVD对CHC患者肝纤维化分期的诊断效能。 结果 观察组的LSM、SSM、PVD分别为(10.28±2.09)kPa、(16.62±2.78)kPa、(12.85±2.03)mm,均高于对照组的(4.35±0.76)kPa、(7.47±1.26)kPa、(10.64±1.59)mm,差异均有统计学意义(t=8.215,t=8.672,t=6.538,P<0.05)。CHC患者肝纤维化S4组LSM、SSM、PVD分别为(17.95±2.26)kPa、(20.63±3.75)kPa、(14.27±2.63)mm,高于S3组[(14.07±2.51)kPa、(18.50±3.06)kPa、(13.49±2.37)mm]、S2组[(10.38±2.16)kPa、(14.59±2.67)kPa、(12.57±2.18)mm]、S1组[(6.72±1.34)kPa、(10.47±2.31)kPa、(11.36±1.84)mm]、S0组[(4.93±0.82)kPa、(8.26±1.45)kPa、(10.85±1.62)mm],差异均有统计学意义(F=25.694,F=18.357,F=11.462,P<0.05)。Pearson相关性分析显示,CHC患者LSM、SSM、PVD与RPR、FIB-4呈正相关,与ALBI呈负相关(P<0.01)。ROC曲线显示,LSM、SSM和PVD单独及三者联合诊断CHC患者肝纤维化分期的AUC分别为 0.758、0.769、0.652和0.846,联合诊断的灵敏度和特异度均高于任一单项效能(P<0.01)。 结论 TE和CDUS联合检测LSM、SSM、PVD,可无创、可靠地诊断并评估CHC患者肝纤维化的病情程度,临床应用价值较高。

关键词: 慢性丙型肝炎, 肝纤维化, 瞬时弹性成像, 肝脏硬度, 脾脏硬度, 门静脉内径

Abstract: Objective To investigate the clinical value of liver hardness (LSM) and spleen hardness (SSM) measured by transient elastography (TE) combined with portal vein diameter (PVD) measured by color Doppler ultrasound (CDUS) to detect the liver fibrosis in chronic hepatitis C (CHC). Methods Ninety-four patients with CHC admitted to the Ultrasound Department of Haian People′s Hospital from June 2021 to October 2023 were included in the observation group, and 70 healthy physical examination personnel were included in the control group during the same period. LSM and SSM values were detected by TE and PVD values were detected by CDUS in both groups. Fasting blood samples were collected to calculate the ratio of red blood cell distribution width to platelet count (RPR), liver fibrosis-4 factor index (FIB-4) and serum albumin-bilirubin (ALBI) levels. Patients in observation group underwent liver biospy under the guidance of CDUS, and liver fibrosis staging was performed according to Scheuer method. The levels of LSM, SSM and PVD in the observation group and the control group at different stages of liver fibrosis were compared. Pearson analysis was used to analyze the correlation between LSM, SSM and PVD and the levels of RPR, FIB-4 and ALBI in CHC patients. Receiver operating characteristic (ROC) curve were used to analyze the diagnostic efficacy of LSM, SSM, and PVD indicators alone and in combination for liver fibrosis staging in CHC patients. Results LSM, SSM and PVD in observation group were (10.28±2.09) kPa, (16.62±2.78) kPa and (12.85±2.03) mm, which were higher than those in control group (4.35±0.76) kPa, (7.47±1.26) kPa, (10.64±1.59) mm. The differences were statistically significant (t=8.215, 8.672, 6.538, all P<0.05). The LSM, SSM and PVD of CHC patients in S4 group were (17.95±2.26) kPa, (20.63±3.75) kPa and (14.27±2.63) mm, which were higher than those in S3 group (14.07±2.51) kPa, (18.50±3.06) kPa and (13.49±2.37) mm. They were (10.38±2.16) kPa, (14.59±2.67) kPa, (12.57±2.18) mm in S2 group and (6.72±1.34) kPa, (10.47±2.31) kPa, (11.36±1.84) mm in S1 group. In S0 group, there were (4.93±0.82) kPa, (8.26±1.45) kPa, (10.85±1.62) mm, and the differences were statistically significant (F=25.694, 18.357, 11.462, all P<0.05). Pearson analysis showed that LSM, SSM and PVD in CHC patients were positively correlated with APRI and FIB-4, and negatively correlated with ALBI (P<0.01). ROC curve showed that the AUC of LSM, SSM and PVD alone or in combination for diagnosing of liver fibrosis stage in CHC patients were 0.758, 0.769, 0.652 and 0.846, respectively, and the sensitivity and specificity of combined diagnosis were higher than that of any single efficacy (P<0.01). Conclusion The combined detection of LSM, SSM and PVD by TE and CDUS can reliably diagnose and evaluate the degree of liver fibrosis in CHC patients, which has high clinical application value.    

Key words: CHC, Hepatic fibrosis, TE, LSM, SSM, PVD